AGM/EGM15 May 2026, 05:01 pm
Gland Pharma: AGM on August 25, 2026; Final Dividend of ₹20 Approved
AI Summary
Gland Pharma Ltd will hold its 48th Annual General Meeting on August 25, 2026, via video conferencing. The board approved the audited financial results for the year ended March 31, 2026, with an unmodified opinion from the statutory auditors. A final dividend of ₹20 (2000%) per equity share of ₹1 each for FY26 was recommended, with a record date of August 11, 2026, for determining eligibility.
Key Highlights
- Gland Pharma's 48th AGM will be held on August 25, 2026, via video conferencing.
- Audited financial results for FY26 received an unmodified opinion from auditors.
- A final dividend of ₹20 per share (2000%) for FY26 was recommended.
- Record date for final dividend eligibility is set for August 11, 2026.
Price Impact
More from GLAND